Dialysis world news


FDA removes certain restrictions from Avandia. PDF Print
FDA: Results from the Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycemia in Diabetes (RECORD) clinical trial showed no elevated risk of heart attack or death in patients being treated with Avandia when compared to standard-of-care diabetes drugs. These data do not confirm the signal of increased risk of heart attacks that was found in a meta-analysis of clinical trials first reported in 2007.

...

 
Abstracts from the American Heart Association Scientific Sessions 2013 PDF Print
Circulation: Contents: Volume 128, Issue 22 Supplement; November 26, 2013 / Abstracts From the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium.

...

 
Nuts ! PDF Print
NEJM: Conclusions. In two large, independent cohorts of nurses and other health professionals, the frequency of nut consumption was inversely associated with total and cause-specific mortality, independently of other predictors of death.

...

 
New study of spironolactone in heart failure fails to show improvement in many hard outcomes. PDF Print
Brigham and Womens Hospital: Boston, MA - A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.

...

 
Advanced CT imaging as good as angiography to detect CAD blockages. PDF Print
EurekAlert: "We found that the 320-detector CT scanner allowed us to see the anatomy of the blockages and determine whether the blockages were causing a lack of perfusion to the heart," sayslead author Carlos E. Rochitte, M.D., a cardiologist at the Heart Institute (InCor), University of Sao Paulo Medical School, in Brazil, "We were therefore able to correctly identify the patients who needed revascularization within 30 days of their evaluation."

...

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 2402
Share |
Copyright © 2014 Global Dialysis. All Rights Reserved.